An investigation of the bactericidal activity of chlorhexidine digluconate against multidrug-resistant hospital isolates

被引:9
|
作者
Ekizoglu, Melike [1 ]
Sagiroglu, Meral [1 ]
Kilic, Ekrem [1 ]
Hascelik, Ayse Gulsen [2 ]
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Microbiol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Med Microbiol, TR-06100 Ankara, Turkey
关键词
Biocides; resistance; chlorhexidine digluconate; quantitative suspension test; EN; 1040; STAPHYLOCOCCUS-AUREUS; REDUCED SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; ANTISEPTICS; DISINFECTANTS; BIOCIDES; EFFICACY;
D O I
10.3906/sag-1503-140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Hospital infections are among the most prominent medical problems around the world. Using proper biocides in an appropriate way is critically important in overcoming this problem. Several reports have suggested that microorganisms may develop resistance or reduce their susceptibility to biocides, similar to the case with antibiotics. In this study we aimed to determine the antimicrobial activity of chlorhexidine digluconate against clinical isolates. Materials and methods: The susceptibility of 120 hospital isolated strains of 7 bacterial genera against chlorhexidine digluconate was determined by agar dilution test, using minimum inhibitory concentration (MIC) values and the EN 1040 Basic Bactericidal Activity Test to determine the bactericidal activity. According to MIC values, Pseudomonas aeruginosa and Stenotrophomonas maltophilia were found to be less susceptible to chlorhexidine digluconate. Results: Quantitative suspension test results showed that 4% chlorhexidine digluconate was effective against antibiotic resistant and susceptible bacteria after 5 min of contact time and can be safely used in our hospital. However, concentrations below 4% chlorhexidine digluconate caused a decrease in bactericidal activity, especially for Staphylococcus aureus and P. aeruginosa. Conclusion: It is crucial to use biocides at appropriate concentrations and to perform surveillance studies to trace resistance or low susceptibility patterns of S. aureus, P. aeruginosa, and other hospital isolates.
引用
收藏
页码:903 / 909
页数:7
相关论文
共 50 条
  • [31] Bactericidal activity of selected medicinal plants against multidrug resistant bacterial strains from clinical isolates
    Chakraborty, Biswajit
    Nath, Anuparn
    Saikia, Himadri
    Sengupta, Mahuya
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2014, 7 : S435 - S441
  • [32] Bactericidal activity and mechanism of action of copper-sputtered flexible surfaces against multidrug-resistant pathogens
    Myriam K. S. Ballo
    Sami Rtimi
    Stefano Mancini
    John Kiwi
    César Pulgarin
    José M. Entenza
    Alain Bizzini
    Applied Microbiology and Biotechnology, 2016, 100 : 5945 - 5953
  • [33] Moxifloxacin - Comparative inhibitory bactericidal activity against susceptible and multidrug-resistant Gram-positive bacteria
    Speciale, A
    Aleo, G
    La Ferla, K
    Musumeci, R
    Caccamo, F
    Nicoletti, G
    DRUGS, 1999, 58 (Suppl 2) : 156 - 159
  • [34] Bactericidal activity and mechanism of action of copper-sputtered flexible surfaces against multidrug-resistant pathogens
    Ballo, Myriam K. S.
    Rtimi, Sami
    Mancini, Stefano
    Kiwi, John
    Pulgarin, Cesar
    Entenza, Jose M.
    Bizzini, Alain
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2016, 100 (13) : 5945 - 5953
  • [35] In vitro Activity of Fosfomycin against Multidrug-Resistant Urinary and Nonurinary Gram-Negative Isolates
    Behera, Bijayini
    Mohanty, Srujana
    Sahu, Subhrajyoti
    Praharaj, Ashok Kumar
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2018, 22 (07) : 533 - 536
  • [36] Activity of tigecycline against multidrug-resistant clinical isolates of Clostridium spp. from Europe
    Hawser, Stephen P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (03) : 310 - 311
  • [37] Antimicrobial activity of propolis special extract GH 2002 against multidrug-resistant clinical isolates
    Astani, A.
    Zimmermann, S.
    Hassan, E.
    Reichling, J.
    Sensch, K. H.
    Schnitzler, P.
    PHARMAZIE, 2013, 68 (08): : 695 - 701
  • [38] In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates
    Zhang, Dan
    Wang, Yufeng
    Lu, Jie
    Pang, Yu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 393 - 399
  • [39] Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone
    Leski, Tomasz A.
    Bangura, Umaru
    Jimmy, David Henry
    Ansumana, Rashid
    Lizewski, Stephen E.
    Stenger, David A.
    Taitt, Chris Rowe
    Vora, Gary J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (01) : 83 - 86
  • [40] Mechanism of Action and Biofilm Inhibitory Activity of Lupinifolin Against Multidrug-Resistant Enterococcal Clinical Isolates
    Sianglum, Wipawadee
    Muangngam, Kanitta
    Joycharat, Nantiya
    Voravuthikunchai, Supayang Piyawan
    MICROBIAL DRUG RESISTANCE, 2019, 25 (10) : 1391 - 1400